Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.

NEW YORK – Early-stage women's health diagnostics firm PinkDx announced on Thursday that it has completed a second close of its $45 million Series A financing round.

The organization is leveraging its growing bank of whole-slide pathology images to create models that could form the backbone of cancer testing applications.